journal article·2022-07

VH298-loaded extracellular vesicles released from gelatin methacryloyl hydrogel facilitate diabetic wound healing by HIF-1α-mediated enhancement of angiogenesis

Yaxi Wang, Zhen Cao, Qian Wei, Kui Ma, Wenzhi Hu, Qilin Huang, Jianlong Su, Haihong Li, Cuiping Zhang, Xiaobing Fu

Acta Biomaterialia· Volume 147
Publisher page

Abstract

Endothelial malfunction is responsible for impaired angiogenesis in diabetic patients, thereby causing the delayed healing progress of diabetic wounds. Exosomes or extracellular vesicles (EVs) have emerged as potential therapeutic vectors carrying drug cargoes to diseased cells. In the present study, EVs were reported as a new treatment for diabetic wounds by delivering VH298 into endothelial cells. Firstly, EVs derived from epidermal stem cells (ESCs) were loaded with VH298 (VH-EVs), and the characteristics of VH-EVs were identified. VH-EVs showed promotive action on the function of human umbilical vein endothelial cells (HUVECs) in vitro by activating HIF-1α signaling pathway. VH-EVs were also found to have a therapeutic effect on wound healing and angiogenesis in vivo. We further fabricated gelatin methacryloyl (GelMA) hydrogel for sustained release of VH-EVs, which possessed high biocompatibility and proper mechanical properties. In diabetic mice, GelMA hydrogel containing VH-EVs (Gel-VH-EVs) effectively promoted wound healing by locally enhancing blood supply and angiogenesis. The underlying mechanism for enhanced angiogenesis was possibly associated with the activation of HIF-1α/VEGFA signaling pathway. Collectively, our findings suggest a promising EV-based strategy for the VH298 delivery to endothelial cells and provide a new bioactive dressing for diabetic wound treatment. STATEMENT OF SIGNIFICANCE: The angiogenic dysfunction is the main cause of diabetic wound unhealing. Extracellular vesicles (EVs) have been reported to be helpful but their efficacy is limited for angiogenesis in cutaneous regeneration. VH298 holds great promise to improve angiogenesis by stabilizing HIF-1α which is reported at low level in diabetic wounds. Here, we loaded EVs with VH298 (VH-EVs) to exert an on-target enhancement of proangiogenic capacity in diabetic wound. Then, we applied a photo-crosslinkable hydrogel, gelatin methacryloyl (GelMA) containing VH-EVs (Gel-VH-EVs) as a convenient biomaterial and an adaptable scaffold for sustained releasing VH-EVs. The results showed significant therapeutic effect of Gel-VH-EVs on skin defect repair. Our findings suggest a promising EVs-based drug delivery strategy and a new functional wound dressing for patients.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Extracellular vesicles in disease · Wound Healing and Treatments · Mesenchymal stem cell research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (50)

Show source-provided references
1. Wound healing and treating wounds: differential diagnosis and evaluation of chronic wounds10.1016/j.jaad.2015.08.068 ↗
2. Wound healing and treating wounds: chronic wound care and management10.1016/j.jaad.2015.08.070 ↗
3. Managing diabetic foot ulcers: pharmacotherapy for wound healing10.1007/s40265-020-01415-8 ↗
4. Curcumin-induced angiogenesis hastens wound healing in diabetic rats10.1016/j.jss.2014.10.019 ↗
5. Working Group on the Diabetic, The 2015 IWGDF guidance documents on prevention and management of foot problems in diabetes: development of an evidence-based global consensus10.1002/dmrr.2694 ↗
6. Chemokines, cytokines, and growth factors in keratinocytes and dermal endothelial cells in the margin of chronic diabetic foot ulcers10.1111/j.1743-6109.2006.00155.x ↗
7. Therapeutic angiogenesis using stem cell-derived extracellular vesicles: an emerging approach for treatment of ischemic diseases10.1186/s13287-019-1276-z ↗
8. Extracellular vesicles from human umbilical cord mesenchymal stem cells facilitate diabetic wound healing through MiR-17-5p-mediated enhancement of angiogenesis10.1007/s12015-021-10176-0 ↗
9. Minimal experimental requirements for definition of extracellular vesicles and their functions: a position statement from the International Society for Extracellular Vesicles10.3402/jev.v3.26913 ↗
10. Application of stem cell-derived exosomes in ischemic diseases: opportunity and limitations10.1186/s12967-021-02863-w ↗
11. The microRNA regulatory landscape of MSC-derived exosomes: a systems view10.1038/s41598-018-19581-x ↗
12. Profile of exosomes related proteins released by differentiated and undifferentiated human keratinocytes10.1002/jcp.21847 ↗
13. Extracellular vesicle-associated proteins in tissue repair10.1016/j.tcb.2020.09.009 ↗
14. Epidermal stem cell-derived exosomes promote skin regeneration by downregulating transforming growth factor-beta1 in wound healing10.1186/s13287-020-01971-6 ↗
15. Exosome-mediated delivery of kartogenin for chondrogenesis of synovial fluid-derived mesenchymal stem cells and cartilage regeneration10.1016/j.biomaterials.2020.120539 ↗
16. Drug loading techniques for exosome-based drug delivery systems10.31083/ph.2021.0128 ↗
17. Systematic review of targeted extracellular vesicles for drug delivery - Considerations on methodological and biological heterogeneity10.1016/j.jconrel.2019.06.006 ↗
18. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes10.1038/nbt.1807 ↗
19. Potent and selective chemical probe of hypoxic signalling downstream of HIF-alpha hydroxylation via VHL inhibition10.1038/ncomms13312 ↗
20. Hyperglycemia regulates hypoxia-inducible factor-1alpha protein stability and function10.2337/diabetes.53.12.3226 ↗
21. Sustained expression of Hif-1alpha in the diabetic environment promotes angiogenesis and cutaneous wound repair10.1111/j.1524-475X.2007.00278.x ↗
22. A small molecule HIF-1alpha stabilizer that accelerates diabetic wound healing10.1038/s41467-021-23448-7 ↗
23. GMSC-derived exosomes combined with a chitosan/silk hydrogel sponge accelerates wound healing in a diabetic rat skin defect model10.3389/fphys.2017.00904 ↗
24. Exosomes/tricalcium phosphate combination scaffolds can enhance bone regeneration by activating the PI3K/Akt signaling pathway10.1186/s13287-016-0391-3 ↗
25. Preservation of small extracellular vesicle in gelatin methacryloyl hydrogel through reduced particles aggregation for therapeutic applications10.2147/IJN.S334194 ↗
26. miR-23a-3p-abundant small extracellular vesicles released from Gelma/nanoclay hydrogel for cartilage regeneration10.1080/20013078.2020.1778883 ↗
27. Reduced graphene oxide incorporated GelMA hydrogel promotes angiogenesis for wound healing applications10.2147/IJN.S218120 ↗
28. GelMA combined with sustained release of HUVECs derived exosomes for promoting cutaneous wound healing and facilitating skin regeneration10.1007/s10735-020-09877-6 ↗
29. Extracellular vesicles as a next-generation drug delivery platform10.1038/s41565-021-00931-2 ↗
30. Synthesis, properties, and biomedical applications of gelatin methacryloyl (GelMA) hydrogels10.1016/j.biomaterials.2015.08.045 ↗
31. Cell-laden microengineered gelatin methacrylate hydrogels10.1016/j.biomaterials.2010.03.064 ↗
32. Extracellular vesicles as modulators of wound healing10.1016/j.addr.2018.01.018 ↗
33. Embryonic stem cell extracts improve wound healing in diabetic mice10.1007/s00592-020-01500-0 ↗
34. Stabilization of HIF-1alpha is critical to improve wound healing in diabetic mice10.1073/pnas.0805230105 ↗
35. Normalizing HIF-1alpha signaling improves cellular glucose metabolism and blocks the pathological pathways of hyperglycemic damage10.3390/biomedicines9091139 ↗
36. Exosomes: the next generation of endogenous nanomaterials for advanced drug delivery and therapy10.1016/j.actbio.2018.12.045 ↗
37. Mesenchymal stem cell-derived extracellular vesicles in tissue regeneration10.1177/0963689720908500 ↗
38. Mesenchymal stromal cells-exosomes: a promising cell-free therapeutic tool for wound healing and cutaneous regeneration10.1186/s41038-019-0178-8 ↗
39. MSC-derived extracellular vesicles to heal diabetic wounds: a systematic review and meta-analysis of preclinical animal studies10.1007/s12015-021-10164-4 ↗
40. Epidermal stem cells in wound healing and their clinical applications10.1186/s13287-019-1312-z ↗
41. Development of exosome-encapsulated paclitaxel to overcome MDR in cancer cells10.1016/j.nano.2015.10.012 ↗
42. Exosome loaded alginate hydrogel promotes tissue regeneration in full-thickness skin wounds: an in vivo study10.1002/jbm.a.36835 ↗
43. The biological and clinical basis for the use of adipose-derived stem cells in the field of wound healing10.1016/j.amsu.2017.06.058 ↗
44. Exosomes from adipose-derived stem cells overexpressing Nrf2 accelerate cutaneous wound healing by promoting vascularization in a diabetic foot ulcer rat model
45. Free and hydrogel encapsulated exosome-based therapies in regenerative medicine10.1016/j.lfs.2020.117447 ↗
46. Applications of Gelatin Methacryloyl (GelMA) Hydrogels in Microfluidic Technique-Assisted Tissue Engineering10.3390/molecules25225305 ↗
47. Synthesis and Properties of Gelatin Methacryloyl (GelMA) hydrogels and their recent applications in load-bearing tissue
48. Magnetic PVA/laponite RD hydrogel nanocomposites for adsorption of model protein BSA10.1007/s00289-018-2480-1 ↗
49. In vivo printing of growth factor-eluting adhesive scaffolds improves wound healing
50. Efficient angiogenesis-based diabetic wound healing/skin reconstruction through bioactive antibacterial adhesive ultraviolet shielding nanodressing with exosome release10.1021/acsnano.9b03656 ↗